BLUE logo

Bluebird Bio (BLUE) Cash From Financing

Annual CFF

$196.25 M
+$178.73 M+1020.20%

December 31, 2023


Summary


Performance

BLUE Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLUEcash flowmetrics:

Quarterly CFF

-$6.11 M
-$44.00 K-0.73%

September 30, 2024


Summary


Performance

BLUE Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLUEcash flowmetrics:

TTM CFF

$159.06 M
+$5.73 M+3.74%

September 30, 2024


Summary


Performance

BLUE TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLUEcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

BLUE Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1020.2%-109.4%+9.2%
3 y3 years-64.1%+83.4%+807.9%
5 y5 years-73.4%-246.1%+2231.5%

BLUE Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+308.9%-105.3%+96.5%-18.9%+232.9%
5 y5-year-64.1%+308.9%-101.1%+96.5%-71.1%+232.9%
alltimeall time-81.8%+308.9%-100.9%+96.5%-88.0%+232.9%

Bluebird Bio Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$6.11 M(+0.7%)
$159.06 M(+3.7%)
Jun 2024
-
-$6.06 M(-109.4%)
$153.32 M(+5.2%)
Mar 2024
-
$64.64 M(-39.3%)
$145.72 M(-25.7%)
Dec 2023
$196.25 M(+1020.2%)
$106.58 M(-1000.4%)
$196.25 M(+271.5%)
Sep 2023
-
-$11.84 M(-13.4%)
$52.82 M(-52.4%)
Jun 2023
-
-$13.67 M(-111.9%)
$110.98 M(-16.4%)
Mar 2023
-
$115.18 M(-412.6%)
$132.69 M(+657.4%)
Dec 2022
$17.52 M(-118.6%)
-$36.85 M(-179.5%)
$17.52 M(-114.6%)
Sep 2022
-
$46.33 M(+476.6%)
-$119.65 M(+32.8%)
Jun 2022
-
$8.03 M(>+9900.0%)
-$90.10 M(-7.8%)
Mar 2022
-
$9000.00(-100.0%)
-$97.74 M(+4.0%)
Dec 2021
-$93.95 M(-117.2%)
-$174.01 M(-329.4%)
-$93.95 M(-215.3%)
Sep 2021
-
$75.87 M(>+9900.0%)
$81.49 M(+1094.5%)
Jun 2021
-
$396.00 K(-89.6%)
$6.82 M(-98.8%)
Mar 2021
-
$3.80 M(+165.1%)
$549.55 M(+0.5%)
Dec 2020
$546.72 M(+2480.4%)
$1.43 M(+19.5%)
$546.72 M(-0.1%)
Sep 2020
-
$1.20 M(-99.8%)
$547.29 M(-0.5%)
Jun 2020
-
$543.12 M(>+9900.0%)
$550.27 M(+4513.6%)
Mar 2020
-
$963.00 K(-52.0%)
$11.93 M(-43.7%)
Dec 2019
$21.19 M(-97.1%)
$2.00 M(-52.0%)
$21.19 M(+0.4%)
Sep 2019
-
$4.18 M(-12.6%)
$21.10 M(-96.9%)
Jun 2019
-
$4.78 M(-53.2%)
$675.72 M(-0.1%)
Mar 2019
-
$10.22 M(+432.2%)
$676.24 M(-8.3%)
Dec 2018
$737.69 M
$1.92 M(-99.7%)
$737.69 M(-44.3%)
Sep 2018
-
$658.79 M(>+9900.0%)
$1.32 B(+97.2%)
Jun 2018
-
$5.30 M(-92.6%)
$671.43 M(-40.6%)
DateAnnualQuarterlyTTM
Mar 2018
-
$71.68 M(-87.8%)
$1.13 B(+5.1%)
Dec 2017
$1.08 B(+345.6%)
$588.33 M(+9513.3%)
$1.08 B(+47.9%)
Sep 2017
-
$6.12 M(-98.7%)
$727.62 M(+0.5%)
Jun 2017
-
$464.85 M(+2655.3%)
$723.93 M(+180.8%)
Mar 2017
-
$16.87 M(-93.0%)
$257.77 M(+6.7%)
Dec 2016
$241.53 M(-50.4%)
$239.77 M(+9755.0%)
$241.53 M(+8594.5%)
Sep 2016
-
$2.43 M(-285.6%)
$2.78 M(-17.0%)
Jun 2016
-
-$1.31 M(-305.2%)
$3.35 M(-99.3%)
Mar 2016
-
$639.00 K(-37.2%)
$484.89 M(-0.4%)
Dec 2015
$486.72 M(+35.8%)
$1.02 M(-66.1%)
$486.72 M(-33.5%)
Sep 2015
-
$3.00 M(-99.4%)
$732.01 M(-12.8%)
Jun 2015
-
$480.24 M(>+9900.0%)
$839.26 M(+133.0%)
Mar 2015
-
$2.46 M(-99.0%)
$360.25 M(+0.5%)
Dec 2014
$358.45 M(+239.3%)
$246.31 M(+123.4%)
$358.45 M(+219.0%)
Sep 2014
-
$110.25 M(+8899.6%)
$112.37 M(>+9900.0%)
Jun 2014
-
$1.23 M(+82.6%)
$948.00 K(-99.1%)
Mar 2014
-
$671.00 K(+188.0%)
$106.69 M(+1.0%)
Dec 2013
$105.64 M(+76.5%)
$233.00 K(-119.7%)
$105.64 M(+0.2%)
Sep 2013
-
-$1.18 M(-101.1%)
$105.39 M(-36.7%)
Jun 2013
-
$106.97 M(<-9900.0%)
$166.43 M(+179.9%)
Mar 2013
-
-$381.00 K(+2440.0%)
$59.47 M(-0.6%)
Dec 2012
$59.85 M(+84.5%)
-$15.00 K(-100.0%)
$59.85 M(-0.0%)
Sep 2012
-
$59.86 M(>+9900.0%)
$59.87 M(>+9900.0%)
Jun 2012
-
$8000.00(>+9900.0%)
$8000.00(>+9900.0%)
Mar 2012
-
$0.00
$0.00
Dec 2011
$32.44 M
-
-

FAQ

  • What is bluebird bio annual cash flow from financing activities?
  • What is the all time high annual CFF for bluebird bio?
  • What is bluebird bio annual CFF year-on-year change?
  • What is bluebird bio quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for bluebird bio?
  • What is bluebird bio quarterly CFF year-on-year change?
  • What is bluebird bio TTM cash flow from financing activities?
  • What is the all time high TTM CFF for bluebird bio?
  • What is bluebird bio TTM CFF year-on-year change?

What is bluebird bio annual cash flow from financing activities?

The current annual CFF of BLUE is $196.25 M

What is the all time high annual CFF for bluebird bio?

bluebird bio all-time high annual cash flow from financing activities is $1.08 B

What is bluebird bio annual CFF year-on-year change?

Over the past year, BLUE annual cash flow from financing activities has changed by +$178.73 M (+1020.20%)

What is bluebird bio quarterly cash flow from financing activities?

The current quarterly CFF of BLUE is -$6.11 M

What is the all time high quarterly CFF for bluebird bio?

bluebird bio all-time high quarterly cash flow from financing activities is $658.79 M

What is bluebird bio quarterly CFF year-on-year change?

Over the past year, BLUE quarterly cash flow from financing activities has changed by -$70.75 M (-109.44%)

What is bluebird bio TTM cash flow from financing activities?

The current TTM CFF of BLUE is $159.06 M

What is the all time high TTM CFF for bluebird bio?

bluebird bio all-time high TTM cash flow from financing activities is $1.32 B

What is bluebird bio TTM CFF year-on-year change?

Over the past year, BLUE TTM cash flow from financing activities has changed by +$13.34 M (+9.15%)